Search

everythinglearnresearchcommunity

for

Search:↓

Low levels of vitamin B12 and ferritin are linked to early hair graying.

Mesalazine may help treat extensive alopecia areata effectively.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Weight loss can cause temporary hair loss, especially in women and older adults.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Thorough history taking is crucial for diagnosing hypothyroidism in rheumatoid arthritis patients.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

Alopecia areata does not affect areas with psoriasis plaques.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Some people with chronic hair loss may have thyroid autoimmunity.